Amneal Pharmaceuticals (AMRX) PT Raised to $25 at UBS on Near Term Growth Drivers
Tweet Send to a Friend
(Updated - August 3, 2026 10:05 AM EDT)
UBS analyst Ashwani Verma raised the price target on Amneal Pharmaceuticals ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
UBS analyst Ashwani Verma raised the price target on Amneal Pharmaceuticals ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
